No abstract available
MeSH terms
-
Advisory Committees
-
COVID-19
-
Comorbidity
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / immunology
-
Dermatitis, Atopic / drug therapy
-
Dermatitis, Atopic / epidemiology*
-
Dermatitis, Atopic / immunology
-
Europe
-
Female
-
Humans
-
Immunocompromised Host / drug effects
-
Immunosuppressive Agents / therapeutic use*
-
Male
-
Pandemics
-
Pneumonia, Viral / epidemiology*
-
Pneumonia, Viral / immunology
-
Practice Guidelines as Topic*
-
Risk Assessment
-
Severe Acute Respiratory Syndrome / epidemiology*
-
Severe Acute Respiratory Syndrome / immunology
-
Treatment Outcome